SCHEMBL29626604

SCHEMBL29626604

OC1CCN(c2ccnc3cn[nH]c23)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 1/20 0.44
▸ HSP90AB1 P08238 1/20 0.44
▸ PIK3CA P42336 2/20 0.39
▸ PIK3CD O00329 1/20 0.39
▸ PIK3CB P42338 1/20 0.39
▸ ATR Q13535 1/20 0.39
▸ ATRIP Q8WXE1 1/20 0.39
▸ ACVR1 Q04771 1/20 0.39
▸ AKT2 P31751 1/20 0.38
▸ LMNA P02545 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ NUDT1 P36639 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ ADRB2 P07550 1/20 0.35
▸ NCF1 P14598 1/20 0.35
▸ ROCK2 O75116 3/20 0.35
▸ ROCK1 Q13464 3/20 0.35
▸ CDC42BPB Q9Y5S2 3/20 0.35
▸ METAP2 P50579 1/20 0.34
▸ PDE10A Q9Y233 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31513726 0.77 PIK3CD (0.35) PIK3CAPIK3CDPIK3CBACVR1HTT
SCHEMBL28741988 0.75 HSP90AA1 (0.43) HSP90AA1HSP90AB1ATRATRIPLMNA
SCHEMBL31092002 0.75 HSP90AA1 (0.43) HSP90AA1HSP90AB1ATRATRIPLMNA
SCHEMBL29626563 0.72 HSP90AA1 (0.40) HSP90AA1HSP90AB1ATRATRIPAKT2
SCHEMBL10564742 0.68 PARP1 (0.39) ATRATRIPALDH1A1
SCHEMBL15421896 0.67 AKT2 (0.48) AKT2NUDT1ROCK2ROCK1CDC42BPB
SCHEMBL12612274 0.67 AKT2 (0.48) AKT2NUDT1ROCK2ROCK1CDC42BPB
SCHEMBL3466097 0.66 HTT (0.41) ACVR1HTT
SCHEMBL29951183 0.65 HTT (0.41) ACVR1HTTMETAP2
SCHEMBL25584612 0.65 CYP46A1 (0.42) HSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114450271-B Ureas, amino and substituted heteroaryl compounds for Cbl-b inhibition 纽力克斯治疗公司 2024-09-20 — — CN disclosed
EP-4003965-A1 UREA, AMIDE, AND SUBSTITUTED HETEROARYL COMPOUNDS FOR CBL-B INHIBITION Nurix Therapeutics, Inc. (US) 2022-06-01 — — EP disclosed
Send feedback